The Antibody Drug Conjugates Market is also supported by increasing interest in combination therapies. Researchers are assessing ADCs alongside immunotherapies, targeted medicines, and other anticancer treatments to explore complementary mechanisms of action.
The Antibody Drug Conjugates Market size is projected to reach US$ 38,077.45 million by 2031 from US$ 8,105.65 million in 2023,...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek